Shannon Fernando

🧵 Long-term outcomes after #ECMO are lacking in the literature. A brief thread on our new paper in @JAMA_current, looking at mental health outcomes in survivors after ECMO (OPEN ACCESS). Thrilled to have presented the results live @ESICM #LIVES2022 jamanetwork.com/journals/jama/…

@DeptSurgeryCS @fdossa @CFerroneMD @AGangiMD @CSCancerCenter @DeptSurgeryCS congratulations on recruiting an absolute superstar!

Join us in welcoming our new faculty to the Department of #Surgery, Dr. Fahima Dossa @fdossa in Surgical Oncology! @CFerroneMD @AGangiMD @CSCancerCenter

⚙️ Curious re the long term outcomes of ECMO & iMV? 🫁 👀 Check out N Jawa & @shanfernands’s new 🌟editorial🌟 on L Rose et al’s study in #journal_CHESTCritCare: Ed: chestcc.org/article/S2949-… Art: chestcc.org/article/S2949-…

We're expanding our group! If you want to work with an amazing team in a terrific city, please consider applying! Please share widely. canadiancriticalcare.org/Job-Postings/

A devastating loss. A brilliant clinician-scientist, and a genuinely amazing human being. I have no words.

Another output from superstar fellow @JungRichardG - Prognostic factors associated with mortality in septic shock: a systematic review and meta-analysis - out in @LancetRespirMed Downloadable: authors.elsevier.com/a/1mWi%7E7tFB1… Kudos to @SameerKadri12 for the accompanying editorial. In fields like cardiogenic (evidence.nejm.org/doi/full/10.10…) and septic shock we generate large amounts of prognostic data that live individually in studies published across time, journals etc. These findings have important implications for clinical and research applications but it can be difficult to understand these factors comparatively. In our publication, we boiled the data down to 95 eligible studies that included 4.8 million eligible patients. We divided the analysis into patient, presentation factors and biochemical markers as they related to in-hospital or 30-d mortality. Significant patient factors included black race, history of cirrhosis or malignancy. Significant presentation risk factors included respiratory source, AKD or elevated risk score (SOFA>APACHE>SAPSII) Significant treatment/biochemical risk factors included need for NE or mechanical ventilation. The identification of these prognostic factors could aid in clinical risk application, goals of care discussions, and identifying the subset of patients at highest and lowest risk of early mortality for patients with septic shock. Kudos to co-authors and collaborators @shanfernands @rebeccamathewmd @Bram_Rochwerg @PietroDiSantoMD @PietroDiSantoMD @GProsperiPorta @cameron_stotts #SEPSIS #SpesisAwareness #StopSepsis #critcare #criticalcare #ICU #CICU @MayoClinicCV @mayoclinicCCM @MayoPCCM @MayoCCJC @UOHI

Kudos to the author team including lead author @shanfernands from our @LakeridgeHealth @queensccm Critical Care faculty! Looking forward to the eventual results of the BLUSH trial underway to provide the randomized evidence needed to evaluate methylene blue in septic shock.

🔍 Methylene blue (MB) use is uncommon in septic shock, with substantial variability across time, patient populations, and hospitals. Randomized evidence is required to evaluate the efficacy and safety of MB. 📖 Read more in CCM: ow.ly/YoTN50Y432S #CritCareMed #SCCM @SCCM

Proud that @LakeridgeHealth has recruited its first patient into the @AlterAKItrial! An RCT designed to test the efficacy of albumin infusion during dialysis in critically ill adults. We are excited to contribute to this important RCT! @edclark75 @CCCTG_ @cmcpher @drrandywax

We just published in @ResusJournal a meta-analysis of MCS after ROSC While only 1 RCT addressed this topic only in CA pts, most RCTs of MCS in AMI-CS enrolled a high proportion of post-CA pts We pooled data from RCTs with available CA subgroups. sciencedirect.com/science/articl… 1/

"I'm stunned that we're standing here talking about the Blue Jays winning the [AL] East." #MLBTonight reacts to Toronto's division clinch.

@drrandywax 😂

The pitching duel I never knew I needed to see…Rowdy Tellez (1B) versus Tyler Heineman (backup C).

🚨📣 A long-awaited study from my #BantingCanada fellowship examining predictors of recurrent #VTE and anticoagulant-related🩸 #bleeding in patients with cancer was published in #EHJ today to coincide with my live presentation at #ISTH2025‼️ academic.oup.com/eurheartj/adva…

🩸 Meta-analysis presented at #ISTH2025 and simultaneously published in @ehj_ed found that several risk factors (e.g., previous history of VTE or bleeding, advanced cancer, and specific cancer sites) are associated with recurrent VTE and bleeding in patients with CAT. academic.oup.com/eurheartj/adva…

@msiuba Congrats Matt! Well deserved.

Very thankful to my fellows for the kind recognition. Teaching engaged learners is a privilege.

Speaker Spotlight! @tomrollinsonPT @shanfernands and Heather O'Grady will be speaking at the 17th World Congress of Intensive and Critical Care! wcicc2025.com/registration #CCCS #WFICC #CSRT #CACCN

@derrickytam @Sunnybrook @DEmersonMD @SmidtHeart @UofTCVsurgery @UofTSurgery Like a boss!!

In April, @Sunnybrook performed first 2 robotic complex mitral repairs by small incisions. Both patients did well, went home in 3 days. Super grateful and privileged to lead this dedicated team. Special thanks @DEmersonMD for proctoring @SmidtHeart @UofTCVsurgery @UofTSurgery

@MarcCarrier1 @isabellemahe1 @NEJM @INNOVTE1 @INVENT_VTE @LaurentBertole1 @FCouturaud @mmonrealriete @AnderCohen @isth @VerhammePeter @Philipp29279657 Congratulations Marc!!

Prof. @isabellemahe1 presents API-CAT at #ACC2025, published in @NEJM Extended anticoagulation with reduced-dose apixaban is noninferior to full-dose for preventing recurrent VTE, with less clinically relevant bleeding 🩸in patients with cancer. nejm.org/doi/full/10.10…

@jamesdownar @CanadianHPCAssn @HPCOntario Congratulations sir - well deserved for all of your advocacy.

A little transatlantic love to start my day…much gratitude to @CanadianHPCAssn and @HPCOntario for this great honour.

Huge congratulations to our very own Dr. Sibley for receiving a @CIHR_IRSC project grant to study magnesium prophylaxis to prevent atrial fibrillation in critically ill patients.

@petrosoniak Exactly the type of knowledge translation we need

@shanfernands 👀👀👀🤣